ReviewTherapeutic advances in hematology2021
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias.
Hanny Al-Samkari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this papertrialcites it